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In May 2010, the White House Task Force on Childhood 
Obesity presented the country with a plan for solving the prob-
lem of childhood obesity within a generation (1). The report 
was the first to provide benchmarks for assessing progress in 
efforts to “bend” the curve of childhood obesity. Starting with a 
baseline prevalence of 16.9% in 2007–2008 (2), the Task Force 
recommended an absolute reduction of obesity rates of 2.5% 
by 2015, another 2.5% reduction by 2020, and the return of 
prevalence to a baseline level of 5% by 2030.
To achieve these goals, both obesity prevention and treat-
ment strategies are required. Prevention alone cannot tackle 
the epidemic given the substantial burden of children already 
classified as obese. Likewise, treatment alone will not be suffi-
cient if obesity incidence remains high among future cohorts of 
children. It is critical for policymakers to better understand the 
optimal balance between approaches. Recent generational pat-
terns of obesity for the US pediatric population and for specific 
racial/ethnic groups will have direct implications for determin-
ing the balance required to reach these policy goals.
Methods
Our intention was to provide basic calculations for general guidance 
about the steps needed to feasibly reach benchmark goals. Although 
we considered constructing a more sophisticated dynamic model of 
 obesity, we chose to create a simple static model as we felt that using 
measures of obesity prevalence, rather than incidence, would be more 
readily accessible to clinicians and policymakers.
Figure 1a shows a schematic of current and future generations of 
US children. Rows represent calendar years, columns represent birth 
cohorts (1989–2028) and numbers within the grid represent age. Base-
line estimates of childhood obesity (2–19 years) for 2008 were based 
on cohorts born in 1989–2006 (yellow highlights). By 2015, the first 
benchmark year, cohorts born in 1989–1995 will have aged out and 
become part of the adult population. Cohorts born in 1996–2006, who 
were part of the 2008 estimate, will remain part of the 2015 estimate, 
which we refer to as “old” cohorts (red highlights). Also included in the 
2015 estimate are individuals from “new” cohorts (born in 2007–2013), 
(blue highlights) who were <2 years-old or were not yet born in 2008. 
“Old” and “new” cohorts are identified for each benchmark year.
We assumed no further obesity incidence among nonobese individuals 
from the “old” cohorts. Therefore, absolute reductions in obesity preva-
lence would occur only as a result of obesity treatment strategies among 
children already obese. In contrast, “new” cohorts would benefit solely 
from obesity prevention strategies for nonobese children. The weighted 
average of obesity prevalence achieved by “old” and “new” cohorts rep-
resents the balance of prevention and treatment necessary to achieve the 
benchmark goals.
For example, overall prevalence estimates achieved for 2015 are the 
weighted average of prevalence (P) of obesity achieved through preven-
tion (PPrevention2015) and through treatment (PTreatment2015). We use the follow-
ing equation, which weights the estimates to account for the proportion 
of “old” and “new” cohorts in the sample (nOld Cohorts = 11 and nNew Cohorts = 7 
for 2015, nOld Cohorts = 13 and nNew Cohorts = 5 for 2020, and nOld Cohorts = 8 and 
nNew Cohorts = 10 for 2030):
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We first assumed that obesity treatment leads to a 1% absolute reduc-
tion in prevalence for the “old” cohort (Figure 1b). Therefore, PTreatment2015 
would be 15.9%, a 1% absolute reduction from the 16.9% in 2008 (2), and 
PBenchmark2015 is 14.4%, the 2015 Task Force goal. For 2020, assuming 2015 
goal prevalence was achieved and a 1% absolute treatment reduction, 
PTreatment2020 would be 13.4% and the 2020 Task Force goal, PBenchmark2020, is 
11.9%. Prevention efforts would therefore need to achieve a PPrevention2020 
of 8% (11.9% = ((13.4% × 13) + (8% × 5))/18). Finally, for 2030, PTreat-
ment2030 would be 10.9% and the 2030 Task Force goal, PBenchmark2030 is 5.0%. 
Prevention efforts would therefore need to achieve a PPrevention2030 of 0.3% 
(5% = ((10.9% × 8) + (0.3% × 10))/18).
We also assume differing levels of absolute treatment effectiveness, 
ranging from 2 to 6%. Table 1 displays the obesity prevalence that preven-
tion efforts would need to achieve to reach the Task Force goals for each of 
the benchmark years under each assumption. Even under optimal condi-
tions in which obesity treatment results in a 6% reduction in prevalence, 
prevention efforts must achieve a prevalence of 4.3% in order to meet the 
Task Force goals. Although our assumptions about treatment effective-
ness could be considered conservative, overall reductions in childhood 
obesity prevalence have not occurred, but instead have plateaued (2), and 
recent meta-analyses evaluating the efficacy of treatment interventions 
for pediatric obesity reveal only small-to-moderate treatment effects for 
short-term BMI reduction (3,4).
Given substantial racial/ethnic disparities in obesity, we performed 
calculations to examine the balance of treatment and prevention needed 
to achieve benchmark goals for minority children (Table 1). Estimates of 
obesity prevalence (for “new” cohorts) by 2030 remained in the 1% range 
or implausible (i.e., negative estimates) for black and Mexican-American 
children even under generous assumptions of treatment effectiveness.
discussion
Our evaluation of the Task Force goals highlights the neces-
sity of pursuing dual strategies of treatment and prevention for 
tackling the epidemic. Because of the heavy burden of obesity 
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Figure 1 Schematic of current and future generations of US children from 2008 through 2030. (a) A schematic of current and future generations of US 
children. Rows represent calendar years, columns represent birth cohorts (1989–2028) and numbers within the grid represent age. Baseline estimates 
of childhood obesity (2–19 years-old) for 2008 were based on cohorts born in 1989 and 2006 (yellow highlights). By 2015, the first benchmark year, 
cohorts born between 1989 and 1995 will have aged out and become part of the adult population. Cohorts born between 1996 and 2006, who 
were part of the 2008 estimate, will remain part of the 2015 estimate, so-called “old” cohorts (red highlights). Also included in the 2015 estimate are 
individuals from “new” cohorts (born between 2007 and 2013) (blue highlights) who were <2-years-old or were not yet born in 2008. Analogously, “old” 
and “new” birth cohorts can be identified for each of the subsequent proposed benchmark years of 2020 (birth cohorts 2001–2013 and 2014–2018), 
and 2030 (birth cohorts 2011–2018 and 2019–2028). (b) A simplified schematic of cohorts with sample calculations. Shown in blue are the estimates of 
obesity prevalence that need to be achieved through prevention efforts, assuming 1% treatment effectiveness. For example, obesity prevalence in 2008 
was 16.9% and would decrease to 15.9% with treatment for the “old” cohorts for 2015. To achieve the Task Force goal of 14.4% by 2015, prevention 
efforts would need to achieve an obesity prevalence of 12% for the “new” cohorts. Assuming that the goal prevalence for 2015 was achieved, obesity 
prevalence in 2020 for the “old” cohorts would decrease to 13.4%. To achieve the Task Force goal of 11.9% by 2020, prevention efforts would need 
to achieve an obesity prevalence of 8% for the “new” cohorts. Finally, assuming that the goal prevalence for 2020 was achieved, obesity prevalence 
in 2030 for the “old” cohorts would decrease to 10.9%. To achieve the Task Force goal of 5.0% for 2030, prevention efforts would need to achieve an 
obesity prevalence of 0.3%, a relatively ambitious goal.
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children, policies focused on development of effective obes-
ity treatment strategies is urgently needed to reach these 
benchmarks.
Current policies have the opportunity to play an important 
role in childhood obesity reduction. For example, the Healthy, 
Hunger-Free Kids Act of 2010 (S.3307) (5), represents a critical 
piece of legislation for reducing childhood obesity. Some of the 
major changes include reauthorization of the National School 
Lunch program and an increase in the number of low-income 
children eligible for free/reduced-price school meals. Policies 
put forth in these bills are largely public health-focused, possibly 
having greater impacts on obesity prevention (6) and may be 
less effective for already obese children, especially given recent 
research reporting the need for comprehensive behavioral and 
lifestyle interventions for successfully reducing BMI among 
obese pediatric populations (4).
Given the larger burden of obesity among minority children, 
there is a crucial need for development of culturally relevant and 
aggressive treatment strategies for this population. There is a 
paucity of studies evaluating the effectiveness of obesity inter-
ventions targeting minority children, although research is slowly 
growing (8). Furthermore, financing for obesity treatment will 
be critical, as lack of coverage for obesity-related services is a 
key barrier for intervening in childhood obesity (9,10). There is 
a significant variability in coverage for obesity prevention- and 
treatment-related services for children by third-party payers 
(11). Medicaid’s Early and Periodic Screening Diagnostic and 
Treatment benefit specifically covers nutritional assessment and 
health interventions to “ameliorate” physical and mental condi-
tions in children; however, only 10 states cover obesity-related 
nutritional and behavioral therapy under this benefit (12).
Given that the Healthy, Hunger-Free Kids Act does not 
specifically address third-party reimbursement for childhood 
obesity treatment, other recent legislation will be critical. 
The Health Care Reform Bill passed in 2010 has a provision 
focused on increasing Medicaid reimbursement for primary 
care services, which is critical given that Medicaid covers a 
disproportionate number of disadvantaged minority children 
(13). Furthermore, this act, which promotes new initiatives and 
funding for prevention of chronic disease, may also be critical 
for addressing treatment, because it will require new health 
plans to cover obesity screening and counseling for children, 
and provides funds for development of demonstration projects 
to create model programs for reducing childhood obesity.
We acknowledge limitations of our study. Our calcula-
tions did not take into account future changes in the popula-
tion distribution by age, cohort, or race/ethnicity. However, 
according to census projections, we likely underestimated 
the obesity prevalence that prevention efforts would need 
to achieve for the overall population, given that Hispanic 
children, who are disproportionately obese, will represent a 
higher proportion of children in the overall US population by 
2030 (14). We also recognize the dynamic nature of obesity 
(15), and the notion that “preventive” policies may have spill-
over “treatment” effects, reducing weight among overweight/
obese children.
Our basic calculations were meant to serve as a heuristic 
example of the treatment and prevention efforts that will be 
necessary to reduce childhood obesity. We realize that indi-
viduals in both “old” and “new” cohorts will share social envi-
ronments such as the family, school, and neighborhood, and 
that the large disparities in obesity prevalence between “old” 
and “new” birth cohorts (i.e., 10.9% for treatment and 0.3% for 
prevention in 2030) that would be needed to reach benchmark 
goals (under low levels of treatment effectiveness) would be 
impractical. However, the profound requirements necessary to 





Reductions in obesity prevalence related to treatment
−1% −2% −3% −4% −5% −6%
Overall (baseline 16.9%) 14.4% 2015 12.0% 13.6% 15.2% 16.8% 18.3% 19.9%
11.9% 2020 8.0% 10.6% 13.2% 15.8% 18.4% 21.0%
5% 2030 0.3% 1.1% 1.9% 2.7% 3.5% 4.3%
Whitesa (baseline 15.3%) 12.8% 2015 10.4% 12% 13.6% 15.2% 16.7% 18.3%
10.3% 2020 6.4% 9% 11.6% 14.2% 16.8% 19.4%
5% 2030 1.6% 2.4% 3.2% 4.0% 4.8% 5.6%
Blacksa (baseline 20%) 17.5% 2015 15.1% 16.7% 18.3% 19.9% 21.4% 23.0%
15% 2020 11.1% 13.7% 16.3% 18.9% 21.5% 24.1%
5% 2030 −2.2% −1.4% −0.6% 0.2% 1.0% 1.8%
Mexican-Americansa (baseline 20.8%) 18.3% 2015 15.9% 17.5% 19.1% 20.7% 22.2% 23.8%
15.8% 2020 11.9% 14.5% 17.1% 19.7% 22.3% 24.9%
5% 2030 −2.8% −2.0% −1.2% −0.4% 0.4% 1.2%
The table shows the obesity prevalence that prevention efforts would need to achieve to reach the Task Force goals for each of the benchmark years under varying 
assumptions of treatment effectiveness (reductions range from 1 to 6%). Values in bold are implausible (negative) values for obesity prevalence, which indicates that even 
if we completely eradicated obesity incidence for “new” cohorts in 2030, goal prevalence would not be reached.
aNote that for the race-specific analyses, 2.5% reductions in obesity by 2015 and 2020, and a return to obesity levels from the 1970s by 2030 (5%) were calculated from 
baseline obesity prevalence rates according to race/ethnicity.
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meet these goals even using these basic models underscores 
how challenging it will be to reduce childhood obesity to reach 
benchmark goals if aggressive treatment and prevention strate-
gies for obesity reduction are not pursued in tandem.
conclusion
In summary, the White House Task Force released a set of 
ambitious goals for “bending the childhood obesity curve” in 
a generation. Both prevention and treatment strategies must 
be pursued to successfully meet these goals, particularly for 
our most vulnerable pediatric populations. Recent health 
care legislation in this country may provide us with a unique 
opportunity to reverse the epidemic of childhood obesity in 
the United States.
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